• 1
    Fine JT, Colditz GA, Coakley EH et al. A prospective study of weight change and health-related quality of life in women. JAMA 1999; 282: 213642.
  • 2
    Kaukua J, Pekkarinen T, Sane T, Mustajoki P. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification – a 2-y follow-up study. Int J Obes Relat Metab Disord 2003; 27: 123341.
  • 3
    Blissmer B, Riebe D, Dye G, Ruggiero L, Greene G, Caldwell M. Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual Life Outcomes 2006; 4: 43.
  • 4
    Samsa GP, Kolotkin RL, Williams GR, Nguyen MH, Mendel CM. Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo. Am J Manag Care 2001; 7: 87583.
  • 5
    Leon-Munoz LM, Guallar-Castillon P, Banegas JR et al. Changes in body weight and health-related quality-of-life in the older adult population. Int J Obes 2005; 29: 138591.
  • 6
    Kaukua JK, Pekkarinen TA, Rissanen AM. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes. Int J Obes Relat Metab Disord 2004; 28: 6005.
  • 7
    Grandy S, Fox KM, Bazata DD, for the SHIELD Study Group. Association of self-reported weight change and quality of life, and exercise and weight management behaviors among adults with type 2 diabetes mellitus. Cardiol Res Pract 2012; 2012: 892564, doi: 10.1155/2012/892564.
  • 8
    American Diabetes Association. Diabetes Statistics. (accessed April 2012).
  • 9
    International Diabetes Federation. Diabetes Atlas. (accessed April 2012).
  • 10
    Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world – a growing challenge. N Engl J Med 2007; 356: 2135.
  • 11
    Centers for Disease Control. Prevalence of overweight and obesity among adults with diagnosed diabetes. (accessed March 2012).
  • 12
    Mukherjee J, McAdam-Marx C, Ye X, Unni SK, Brixner D. Weight loss of 3% or more in a 12-month period is associated with glycaemic control in newly treated type 2 diabetes patients in the usual care setting. Diabetologia 2011; 54 (Suppl. 1): S331 (abstract 861).
  • 13
    Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc 2009; 49 (Suppl. 1): S39.
  • 14
    Bays HE, Chapman RH, Grandy S, for the SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007; 61: 73747.
  • 15
    Bays HE, Bazata DD, Clark NG et al. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health 2007; 7: 277.
  • 16
    US Census Bureau. Annual Supplement to the Current Population Survey: Census Bureau Resident Population Estimates of the United States. Washington, DC: US Census Bureau, 2003.
  • 17
    Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002; 5: 5615.
  • 18
    Vila-Funes JA, Gutierrez-Robledo LM, Ponce de leon Rosales S. Validity of height and weight self-report in Mexican adults: results from the national health and aging study. J Nutr Health Aging 2004; 8: 35561.